论文部分内容阅读
本文探讨院外室颤(VF)幸存者安置埋藏式复律除颤器(ICD)辅以抗心律失常药(AAD)后,ICD放电的临床预测指标。 方法 作者从1988年到1991年西雅图心脏骤停幸存者常规AAD和胺碘酮治疗对比试验(CASCADE)资料中,选择安置ICD的冠心病患者88例,包括常规AAD组42例和胺碘酮组46例作为研究对象。CASCADE的入选对象均具有近期院外VF发作史,但与
This article investigates the clinical predictors of ICD discharge following placement of an implantable cardioverter defibrillator (ICD) with antiarrhythmic drug (AAD) in patients with ventricular fibrillation (VF) survivors. METHODS: From 1988 to 1991, Seattle Cardiac Arrest Survivors Conventional AAD and Amiodarone Comparison Study (CASCADE) data, 88 patients with coronary heart disease selected for placement of ICD were enrolled, including 42 patients in the conventional AAD group and amiodarone group 46 cases as the research object. CASCADE’s inclusion of patients with recent history of out-of-hospital VF episodes, but with